Cargando…

Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention

BACKGROUNDS: Diabetes mellitus is an independent risk factor for Contrast-induced nephropathy (CIN) in patients undergoing Coronary arteriography (CAG)/percutaneous coronary intervention (PCI). Glycosylated hemoglobin (HbA1c) is the gold standard to measure blood glucose control, which has important...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, H., Fu, H., Fu, X., Zhang, J., Zhang, P., Yang, S., Zeng, Z., Fu, N., Guo, Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173735/ https://www.ncbi.nlm.nih.gov/pubmed/34078303 http://dx.doi.org/10.1186/s12882-021-02405-y

Ejemplares similares

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
por: Shoukat, Sana, et al.
Publicado: (2010)

Periprocedural Hemoglobin Drop and Contrast-Induced Nephropathy in Percutaneous Coronary Intervention Patients
por: Lee, Kang Hyu, et al.
Publicado: (2010)

Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions
por: Li, Wen-hua, et al.
Publicado: (2012)

Coronary Arteriography: The Diagnosis of Coronary Artery Disease
por: Dow, J. D.
Publicado: (1974)

Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention
por: Zheng, Jia, et al.
Publicado: (2016)

Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
por: Zhang, Jun-yi, et al.
Publicado: (2019)

Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Zhu, Boqian, et al.
Publicado: (2016)

Predictive value of preprocedural albuminuria for contrast-induced nephropathy non-recovery in patients undergoing percutaneous coronary intervention
por: Chen, Hanchuan, et al.
Publicado: (2021)

Risk factors of contrast-induced nephropathy in patients with STEMI and pump failure undergoing percutaneous coronary intervention
por: Chen, Hongwu, et al.
Publicado: (2021)

Compound Danshen Dripping Pill Pretreatment to Prevent Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Yang, Rong, et al.
Publicado: (2014)

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Periprocedural Hemoglobin Changes and Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Alizadeh, Keivan, et al.
Publicado: (2013)

Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
por: HE, HAIYAN, et al.
Publicado: (2014)

Effects of remote ischemic preconditioning on contrast induced nephropathy after percutaneous coronary intervention in patients with acute coronary syndrome
por: Zhou, Fazhan, et al.
Publicado: (2018)

Hyperuricemia may be related to contrast-induced nephropathy after percutaneous coronary intervention
por: Demirkol, Sait, et al.
Publicado: (2013)

Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis
por: Wang, Jing, et al.
Publicado: (2021)

Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention
por: Barbieri, Lucia, et al.
Publicado: (2022)

Reduction of Circulating Endothelial Progenitor Cell Level Is Associated with Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary and Peripheral Interventions
por: Chiang, Chia-Hung, et al.
Publicado: (2014)

Albert Bruschke (1935–2022), a pioneer of coronary arteriography
por: van Hemel, Norbert, et al.
Publicado: (2023)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
por: Firouzi, Ata, et al.
Publicado: (2018)

Glycemic variability as predictor of contrast-induced nephropathy in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Zuo, Pengfei, et al.
Publicado: (2020)

Prognostic Value of Hemoglobin A1c Levels in Postmenopausal Diabetic Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome
por: Lao, Yi, et al.
Publicado: (2018)

Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review
por: Sacha, Jerzy, et al.
Publicado: (2019)

Incidence and Risk Factors of Contrast-Induced Nephropathy after Bronchial Arteriography or Bronchial Artery Embolization
por: Song, June Seok, et al.
Publicado: (2013)

Risk Factors Associated With Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention
por: Kumar, Dileep, et al.
Publicado: (2020)

Arteriography
por: Demel, R.
Publicado: (1938)

Arteriography
Publicado: (1930)

Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Tang, Chengchun, et al.
Publicado: (2019)

Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Khalfallah, Mohamed, et al.
Publicado: (2021)

The triglyceride-glucose index and contrast-induced nephropathy in non-ST elevation myocardial infarction patients undergoing percutaneous coronary intervention
por: Gursoy, Erol, et al.
Publicado: (2023)

Correlation of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) with Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Interventions
por: Butt, Khurram, et al.
Publicado: (2020)

Preventive effect of reduced glutathione on contrast-induced nephropathy in elderly patients undergoing coronary angiography or intervention: a randomized, controlled trial
por: Jin, B., et al.
Publicado: (2015)

Contrast volume and in-hospital outcomes of dialysis patients undergoing percutaneous coronary intervention
por: Kuno, Toshiki, et al.
Publicado: (2022)

Predictive Value of Galectin-3 and Brachial-Ankle Pulse Wave Velocity for Coronary Artery Calcification in Coronary Arteriography Patients
por: Tian, Lei, et al.
Publicado: (2022)

Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced Nephropathy
por: Yun, Kyeong Ho, et al.
Publicado: (2014)

Contrast-induced Nephropathy Following Percutaneous Coronary Intervention at a Tertiary Cardiac Center in Nepal
por: Mandal, Amrendra, et al.
Publicado: (2018)

The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention
por: Zhao, Jingjing, et al.
Publicado: (2020)

Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography
por: Wang, Mian, et al.
Publicado: (2016)

Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
por: Liu, Yong, et al.
Publicado: (2014)

A New and Simple Risk Predictor of Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention: TIMI Risk Index
por: Kaya, Ahmet, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9p00kot49vmnb4cjpsj5n0btdk